Medical Condition News

RSS

ZEUS trial challenges assumptions about targeting inflammation in heart disease

Like cholesterol, inflammation causally contributes to the risk of cardiovascular disease, but findings from the clinical trial ZEUS indicate that the road to targeting inflammation may be less straightforward than once thought.

8 Nov 2026

MD Anderson and P-Cure join hands to advance proton and helium ion therapy

The University of Texas MD Anderson Cancer Center and P-Cure Ltd. today announced a strategic alliance to advance the development and clinical validation of a next-generation particle therapy platform designed to deliver both proton and helium ion therapy from a single compact upright treatment system.

8 Nov 2026

Retatrutide reduces knee pain and body weight in osteoarthritis patients

For people with painful knee osteoarthritis (OA) who are overweight or have obesity, everyday activities such as walking, climbing stairs and standing up from a chair can be difficult.

8 Nov 2026

GLP-1 weight-loss drugs may change what you crave, not just how much you eat

A prospective observational pilot study of 38 adults without diabetes found that three months of semaglutide or tirzepatide treatment was associated with an average weight loss of 7.2 kg, reduced food cravings, increased satiety, and improved self-reported hunger control. Most participants reported smaller meal portions, while some experienced changes in food preferences, although the study could not establish whether the medications directly caused these behavioral changes.

8 Nov 2026

Red meat and ultra-processed foods show no clear link to postpartum depression in new study

A prospective cohort study of 264 pregnant Iranian women found no statistically significant association between maternal consumption of ultra-processed foods or red meat and probable postpartum depression assessed four to six weeks after childbirth. However, the relatively small sample size and imprecise estimates mean that potentially meaningful associations cannot be excluded, highlighting the need for larger studies.

8 Nov 2026

Common overactive bladder drugs may not increase dementia risk

New research, published November 6th in JAMA Network Open, finds anticholinergic medications, commonly prescribe for overactive bladder (OAB), may not increase dementia risk after all compared to beta-3 agonists, the newer drug class that has been presumed to be safer for the brain.

6 Nov 2026

Early diagnosis and treatment help teenager overcome rare epilepsy

Christopher Sepúlveda was just 2 years old when his parents noticed something was wrong. Christopher began experiencing involuntary movements of his mouth and eyes, and episodes when he would freeze and not move for nearly two minutes- something their pediatrician at the time said could be a tic disorder.

6 Nov 2026

Seasonal allergies may be driving recurrent sinus infections

"Every spring, I get sick. Then it happens again in the fall." If you have frequent sinus symptoms that follow a seasonal pattern, allergies may be the root cause. Seasonal allergies can cause congestion, drainage, facial pressure, and fatigue.

6 Nov 2026

Epidemiologist investigates environmental risks to protect vulnerable cancer patients

Judy Ou, PhD, MPH, is an epidemiologist-which is, according to her, "the nerdiest kind of detective ever."

6 Nov 2026

Frequent anxiety may reflect worsening cognitive function in Alzheimer's disease

Ask the family of someone with Alzheimer's disease what the hardest part is, and the answer is not always the forgetting. Sometimes it is the pacing.

6 Nov 2026

Tai Chi and exercise may improve sleep in older cancer survivors

There is an hour of the night that belongs to no one. The house has gone still, the furnace has stopped ticking, and a man who beat cancer some years ago lies on his back, counting nothing in particular. He is not alone.

6 Nov 2026

NIH award supports research into ovarian cancer and neural connections

One of the biggest breakthroughs in modern cancer treatment doesn't attack cancer directly. Instead, immunotherapy harnesses the body's immune system to recognize and destroy cancer cells.

6 Nov 2026

Immune cell differences may explain sex-specific obesity responses

University of California, Riverside scientists have an explanation for why males and females respond differently to obesity.

6 Nov 2026

Pancreatic cancer shows distinct biological differences across racial groups

New research from the University of Cincinnati Cancer Center found biological differences in pancreatic cancer tumors and immune environments, opening the possibility for more personalized treatments for different populations.

6 Nov 2026

Ketamine may strengthen mindfulness therapy for opioid use disorder

Researchers from University of California San Diego School of Medicine have found that adding ketamine to a mindfulness-based treatment for opioid use disorder may strengthen people's ability to recognize and respond to signals from their bodies - changes that may help reduce opioid cravings.

6 Nov 2026

IITGN research explores new approach to tackling drug-resistant glioblastoma

Cancer remains among the most deadly diseases worldwide. Globally, more than 300,000 new cases of brain cancer are reported each year, with glioblastoma, an aggressive form of brain cancer, accounting for over 250,000 deaths.

6 Nov 2026

Harvard-led team receives $7 million to develop AI co-scientists for cancer research

A team led by Marinka Zitnik, associate professor of biomedical informatics in the Blavatnik Institute at Harvard Medical School, has received a grant of nearly $7 million from Cancer Grand Challenges to create artificial intelligence (AI) "co-scientists" that help cancer researchers analyze data, generate hypotheses, and suggest new experiments, speeding new knowledge and therapies.

6 Nov 2026

Stony Brook-developed cancer drug advances to human clinical trials

A promising new cancer chemotherapeutic agent from a taxane class of natural compounds – anti-cancer agents designed to block cell division and trigger the programmed cell death to treat sold tumors – originally developed by researchers at Stony Brook University has entered human clinical trials.

6 Nov 2026

Advanced tumor profiling uncovers hidden hereditary cancer-predisposition syndrome

Using next-generation sequencing (NGS) to profile tumor cells from patients with solid tumors, researchers at Fondazione Policlinico Universitario A. Gemelli IRCCS identified genetic alterations associated with cancer predisposition in 10% of the subjects examined.

6 Nov 2026

Rising grocery prices linked to higher food anxiety and insufficiency

As grocery prices continue to rise, a study by researchers at Penn State found that in addition to increased spending, the price hikes also are associated with higher risk of food insufficiency and worse mental health conditions.

6 Nov 2026